Depression, among other mood disorders, represents one of the most common health
problems worldwide, with steadily increasing incidence and major socio-economic …

Patients with chronic hepatitis C virus (HCV) infection experience a range of symptoms
including depression, fatigue and neurocognitive deficits, impairing quality of life …

Mental health problems frequently occur in chronic infection with the hepatitis C virus (HCV)
and during antiviral treatment with pegylated interferon-alpha (PegIFNα) and ribavirin …

Chronic hepatitis C (CHC) affects over 170 million individuals worldwide and is a growing
public health concern. Despite the availability of CHC treatment, specifically interferon‐α …

Background: The aim of this prospective study was to gain a more comprehensive picture of
the biopsychosocial effects of interferon-α (IFN-α) treatment of patients with chronic hepatitis …

Objective: To assess the utility of prophylactic administration of antidepressants in
preventing a major depressive episode during antiviral treatment for chronic hepatitis C …

Symptomatic Treatment of Interferon-α–Induced Depression in... : Journal of Clinical
Psychopharmacology Symptomatic Treatment of Interferon-α–Induced Depression in Hepatitis …

Depression is a complex disorder with heterogeneous clinical anomalies whose
neurobiological understanding still remains unclear. Medications have been implicated as …

Sleep disturbances occur in up to 60% of patients with chronic hepatitis C (CHC) and is
often interrelated with comorbid psychiatric disorders. Moreover, neuropsychiatric …

Psychiatric comorbidity is a common problem in patients with substance use disorders.
Patients with psychiatric diseases and/or substance abuse have an increased risk for …